Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects
- PMID: 29285766
- DOI: 10.1111/eci.12876
Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects
Abstract
Recent studies have clarified that pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH) has some distinctive clinical aspects from other PAH, such as high prevalence, venous and cardiac involvement, less favourable outcome, helpfulness of detection algorithm, response to immunosuppression, pre-PAH conditions in borderline pulmonary arterial pressure and coexistence of interstitial lung disease. In this review, by focusing on these distinctive aspects, we discuss how to provide an efficacious and safe management of CTD-PAH and garner attention to areas where further evidence is desired.
Keywords: connective tissue diseases; pulmonary arterial hypertension; pulmonary hypertension; systemic lupus erythematosus; systemic sclerosis.
© 2017 Stichting European Society for Clinical Investigation Journal Foundation.
Similar articles
-
[Pulmonary arterial hypertension in connective tissue diseases].Bull Acad Natl Med. 2009 Nov;193(8):1911-8; discussion 1918-9. Bull Acad Natl Med. 2009. PMID: 20669554 French.
-
[Pulmonary arterial hypertension associated with connective tissue diseases].Presse Med. 2014 Sep;43(9):957-69. doi: 10.1016/j.lpm.2014.07.009. Epub 2014 Aug 14. Presse Med. 2014. PMID: 25129118 Review. French.
-
Pulmonary hypertension in connective tissue diseases: an update.Int J Rheum Dis. 2017 Jan;20(1):5-24. doi: 10.1111/1756-185X.13001. Epub 2017 Feb 16. Int J Rheum Dis. 2017. PMID: 28205373 Review.
-
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.Autoimmun Rev. 2024 Apr;23(4):103506. doi: 10.1016/j.autrev.2023.103506. Epub 2023 Dec 21. Autoimmun Rev. 2024. PMID: 38135175 Review.
-
[Pulmonary arterial hypertension in connective tissue disease].Rev Mal Respir. 2006 Sep;23(4 Suppl):13S61-72. Rev Mal Respir. 2006. PMID: 17057632 Review. French.
Cited by
-
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension.Front Cardiovasc Med. 2024 Oct 14;11:1430903. doi: 10.3389/fcvm.2024.1430903. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39469124 Free PMC article.
-
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.Cardiol Ther. 2024 Jun;13(2):315-339. doi: 10.1007/s40119-024-00361-w. Epub 2024 Mar 7. Cardiol Ther. 2024. PMID: 38451426 Free PMC article.
-
Diagnostic and prognostic value of ventilatory power in pulmonary hypertension.Respir Res. 2022 Oct 16;23(1):285. doi: 10.1186/s12931-022-02212-5. Respir Res. 2022. PMID: 36244984 Free PMC article.
-
Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.BMC Pulm Med. 2022 Aug 1;22(1):295. doi: 10.1186/s12890-022-02081-0. BMC Pulm Med. 2022. PMID: 35909128 Free PMC article.
-
Text Mining-Based Drug Discovery for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Front Pharmacol. 2022 Mar 18;13:743210. doi: 10.3389/fphar.2022.743210. eCollection 2022. Front Pharmacol. 2022. PMID: 35370713 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
